IgA nephropathy surgery: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
==Indications== | ==Indications== | ||
*The mainstay of treatment for IgA nephropathy is medical therapy. Surgery is usually reserved for patients with either:<ref name="pmid8325026">{{cite journal |vauthors=Béné MC, Hurault de Ligny B, Kessler M, Foliguet B, Faure GC |title=Tonsils in IgA nephropathy |journal=Contrib Nephrol |volume=104 |issue= |pages=153–61 |date=1993 |pmid=8325026 |doi= |url=}}</ref><ref name="pmid24489644">{{cite journal |vauthors=Nagasawa Y, Iio K, Fukuda S, Date Y, Iwatani H, Yamamoto R, Horii A, Inohara H, Imai E, Nakanishi T, Ohno H, Rakugi H, Isaka Y |title=Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment |journal=PLoS ONE |volume=9 |issue=1 |pages=e81636 |date=2014 |pmid=24489644 |pmc=3904818 |doi=10.1371/journal.pone.0081636 |url=}}</ref> | *The mainstay of treatment for IgA nephropathy is medical therapy. Surgery is usually reserved for patients with either:<ref name="pmid8325026">{{cite journal |vauthors=Béné MC, Hurault de Ligny B, Kessler M, Foliguet B, Faure GC |title=Tonsils in IgA nephropathy |journal=Contrib Nephrol |volume=104 |issue= |pages=153–61 |date=1993 |pmid=8325026 |doi= |url=}}</ref><ref name="pmid24489644">{{cite journal |vauthors=Nagasawa Y, Iio K, Fukuda S, Date Y, Iwatani H, Yamamoto R, Horii A, Inohara H, Imai E, Nakanishi T, Ohno H, Rakugi H, Isaka Y |title=Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment |journal=PLoS ONE |volume=9 |issue=1 |pages=e81636 |date=2014 |pmid=24489644 |pmc=3904818 |doi=10.1371/journal.pone.0081636 |url=}}</ref><ref name="pmid8052439">{{cite journal |vauthors=Odum J, Peh CA, Clarkson AR, Bannister KM, Seymour AE, Gillis D, Thomas AC, Mathew TH, Woodroffe AJ |title=Recurrent mesangial IgA nephritis following renal transplantation |journal=Nephrol. Dial. Transplant. |volume=9 |issue=3 |pages=309–12 |date=1994 |pmid=8052439 |doi= |url=}}</ref> | ||
**IgA nephropathy and recurrent [[Infection|infections]] | **IgA nephropathy and recurrent [[Infection|infections]] | ||
**[[ESRD]] due to IgA nephropathy | |||
==Surgery== | ==Surgery== | ||
Revision as of 22:42, 24 May 2018
|
IgA nephropathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
IgA nephropathy surgery On the Web |
|
American Roentgen Ray Society Images of IgA nephropathy surgery |
|
Risk calculators and risk factors for IgA nephropathy surgery |
Overview
The mainstay of treatment for IgA nephropathy is medical therapy. Tonsillectomy is usually reserved for patients with IgA nephropathy and recurrent infections.
Indications
- The mainstay of treatment for IgA nephropathy is medical therapy. Surgery is usually reserved for patients with either:[1][2][3]
- IgA nephropathy and recurrent infections
- ESRD due to IgA nephropathy
Surgery
- The mainstay of treatment for IgA nephropathy is medical therapy. Tonsillectomy is usually reserved for patients with IgA nephropathy and recurrent infections.[1][2]
References
- ↑ 1.0 1.1 Béné MC, Hurault de Ligny B, Kessler M, Foliguet B, Faure GC (1993). "Tonsils in IgA nephropathy". Contrib Nephrol. 104: 153–61. PMID 8325026.
- ↑ 2.0 2.1 Nagasawa Y, Iio K, Fukuda S, Date Y, Iwatani H, Yamamoto R, Horii A, Inohara H, Imai E, Nakanishi T, Ohno H, Rakugi H, Isaka Y (2014). "Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment". PLoS ONE. 9 (1): e81636. doi:10.1371/journal.pone.0081636. PMC 3904818. PMID 24489644.
- ↑ Odum J, Peh CA, Clarkson AR, Bannister KM, Seymour AE, Gillis D, Thomas AC, Mathew TH, Woodroffe AJ (1994). "Recurrent mesangial IgA nephritis following renal transplantation". Nephrol. Dial. Transplant. 9 (3): 309–12. PMID 8052439.